Distinct Clinical Courses and Shortened Lifespans in Childhood-Onset DNA Polymerase Gamma Deficiency

• Published in: Neurology. Genetics Vol. 10; no. 4; p. e200167
• Main Authors: Rötig, Agnès, Gaignard, Pauline, Barcia, Giulia, Assouline, Zahra, Berat, Claire-Marine, Barth, Magalie, Damaj, Léna, Laborde, Nolwenn, Abi-Warde, Marie-Thérèse, Chabrol, Brigitte, De Lonlay, Pascale, Desguerre, Isabelle, Goldenberg, Alice, Gonzales, Emmanuel, Jacquemin, Emmanuel, Amati -Bonneau, Patrizia, Bonneau, Dominique, Abadie, Véronique, Bonnemains, Chrystèle, Broue, Pierre, De Saint-Martin, Anne, Durand, Philippe, Fouilhoux, Alain, Isidor, Bertrand, Jaroussie, Marianne, Jedraszak, Guillaume, Maurey, Hélène, Mention, Karine, Odent, Sylvie S., Pasquier, Laurent, Rougeot-Jung, Christelle, Gitiaux, Cyril, Roux, Charles-Joris, Boddaert, Nathalie, Munnich, Arnold, Schiff, Manuel
• Format: Journal Article
• Language: English
• Published: Baltimore Wolters Kluwer 01.08.2024; American Academy of Neurology
• Subjects: Genetics; Hematology; Human genetics; Human health and pathology; Life Sciences; PHENOTYPE; NERVE; DISEASES; MUTATIONS; SPECTRUM; ENHANCEMENT
• ISSN: 2376-7839; 2376-7839
• DOI: 10.1212/NXG.0000000000200167

Background and ObjectivesDNA polymerase subunit gamma (POLG) deficiency is likely the most frequent cause of nuclear-encoded mitochondrial disorders. POLG-related disorders reportedly constitute a spectrum of overlapping phenotypes from infancy to late adulthood. We retrospectively reviewed natural histories for 40 children carrying biallelic pathogenic POLG variants.MethodsThe patients were identified by the French coordinating center for mitochondrial disorders (CARAMMEL), making this a large monocentric series on childhood-onset POLG deficiency.ResultsThree patterns of clinical course and survival were observed, distinguished by main category of symptoms: neurologic, hepatic, and gastrointestinal. A total of 24 patients needed urgent neurointensive care for tonic-clonic seizures, myoclonic epilepsy, and status epilepticus, occasionally precipitated by valproate administration. Other neurologic symptoms included dystonia, cerebellar ataxia, and peripheral neuropathy. We report 6 POLG-deficient patients with polyradiculoneuropathy mimicking subacute Guillain-Barré syndrome and provide postgadolinium MRI evidence of diffuse cranial nerve root and cauda equina enhancement, suggesting these disorders have an inflammatory component. Children presenting with enteral nervous system involvement had vomiting, gastroparesis, and chronic intestinal pseudo-obstruction. They had later ages of onset and lived much longer. Primarily, hepatic presentations had the earliest onset and shortest survivals. Secondary hepatic failure was frequently precipitated by valproate administration given before diagnosis to patients with focal impaired awareness seizures or absence of seizures. These POLG deficiencies were often fatal, with age at death ranging from 3 months to 10 years, with a significant difference in survival between the 3 clinical forms; 6 of the 40 children did survive. No genotype-phenotype correlations were found for the 3 clinical course types.DiscussionThe study demonstrates the prevalence of neurologic presentation and the extent of central, peripheral, and autonomous nervous system involvement in 60% of patients. Most of the patients with early onset and rapidly fatal hepatic failure did not live long enough to develop neurologic symptoms. The study revealed a new clinical form of POLG deficiency presenting with neurodigestive symptoms with longer lifespan. We also propose that POLG deficiency should be considered in children presenting with unexplained polyradiculoneuropathy, demyelinating neuropathy, and elevated CSF protein. Finally, valproate administration remains a notable cause of avoidable death in POLG-deficient patients.